C. difficile Toxin A

If you have developed sudden, watery diarrhea during or after a course of antibiotics, hospitalization, or chemotherapy, this test can tell you within hours whether Clostridioides difficile is in your gut. That answer matters because untreated C. difficile infection can progress from nuisance diarrhea to severe colon inflammation, pseudomembranous colitis, toxic megacolon, and in some cases death.

This is a stool test that uses PCR (polymerase chain reaction), a technique that copies and detects specific pieces of DNA. It looks for the gene that codes for toxin A, one of the two main toxins this bacterium uses to damage the gut lining. A positive result does not by itself prove active disease, which is the most important nuance to understand before reading the rest.

What This Test Actually Detects

Stool PCR for C. difficile toxin A detects the toxin gene (called tcdA), not the toxin protein itself. The bacterium carries the gene in a chromosomal region called the pathogenicity locus, and only strains that have these genes can produce disease-causing toxin. Most pathogenic strains carry both the toxin A gene and the toxin B gene. Some strains carry only the toxin B gene and still cause illness, and rarer strains predominantly produce toxin A.

Because the test reads DNA rather than active toxin in your stool, a positive result tells you that a toxin-capable strain is present in your gut. It does not, on its own, tell you whether that strain is actively producing toxin and inflaming your colon right now. This distinction is the source of nearly every interpretation challenge with this test.

Why It Matters: C. difficile Infection

C. difficile infection (CDI) ranges from mild diarrhea to life-threatening pseudomembranous colitis, toxic megacolon, colectomy, ICU admission, and death. The toxins are responsible for the damage: they bind to the cells lining your colon, break down the connections between those cells, trigger inflammation, and kill epithelial cells, which produces the diarrhea and inflammatory injury.

Higher amounts of toxin in stool tend to track with worse disease. In one study, those with severe CDI had toxin levels roughly four times higher than those with milder disease. Very high toxin levels above 2500 pg/mL were associated with about 12 times the odds of death. The PCR test does not measure toxin concentration directly, which is one reason PCR alone is an incomplete picture of severity.

Why It Matters: Colonization vs. Infection

Roughly 10 to 20 percent of hospitalized patients carry C. difficile in their gut without symptoms, with some studies reporting rates as low as 3 percent and as high as 26 percent depending on the setting. Children under age 2 carry it at even higher rates, with nearly half of infants colonized in the first year of life. A PCR test cannot tell carriage apart from active infection. In a large cohort study, patients who tested positive by PCR but negative for stool toxin had outcomes similar to people who tested negative for C. difficile entirely, and they had very few CDI-related complications compared with patients who were both PCR and toxin positive.

This is why a positive PCR in someone without diarrhea, or in someone whose diarrhea has another likely cause, often does not justify treatment. The test is most useful when ordered for clear clinical reasons rather than as a screening study.

Reconciling a Confusing Pattern

It may seem contradictory that a highly sensitive test for a potentially severe infection can produce results that are clinically meaningless. The framework that resolves this: PCR detects whether the bacterium and its toxin gene are present in your gut, not whether disease is actively happening. The same positive result can mean a serious infection, mild illness, or no illness at all. The test is best read as a piece of evidence that combines with your symptoms, recent antibiotic exposure, lab markers like white blood cell count, and often a follow-up toxin assay, rather than as a standalone verdict.

Diagnostic Performance

Among rapid tests for C. difficile, stool PCR is one of the most sensitive options, which makes it strong at ruling the bacterium out when negative.

What this means for you: if your PCR is negative and you have new diarrhea, C. difficile is very unlikely to be the cause. If your PCR is positive, the result is more ambiguous and usually needs to be combined with a toxin assay or with your clinical picture before deciding on treatment.

The Toxin A Gene vs. Toxin B Gene Issue

Historically, toxin A was thought to be the main driver of disease. Current evidence shows that both toxin A and toxin B contribute to illness, and strains exist that lack the toxin A gene but carry the toxin B gene. These toxin A-negative, toxin B-positive strains can still cause symptomatic infection that looks identical to disease from fully toxigenic strains. In one study of Kenyan isolates, more than half of toxigenic strains had a truncated toxin A gene. Because of this, a stool test that only looks at toxin A can miss real cases, and most modern PCR panels include both toxin A and toxin B targets.

When Results Can Be Misleading

Several common situations can make a single PCR result hard to interpret correctly. Knowing these in advance helps you and your clinician avoid acting on the wrong signal.

• Testing without diarrhea: PCR on formed stool or in someone without active diarrhea picks up colonization rather than infection. Liquid stool from a symptomatic person is the only appropriate sample.
• Recent laxatives: If you have taken laxatives in the prior 48 hours, the diarrhea may be drug-induced rather than infectious, and a positive PCR is more likely to reflect colonization.
• Specimen handling: Delays in transport or improper storage can degrade samples and reduce the accuracy of toxin assays, even when PCR is positive. Follow your lab's specific collection and transport instructions.
• Young children: Healthy infants and toddlers commonly carry C. difficile. PCR positivity in a child under age 2 does not reliably indicate disease and is not recommended for diagnosis in that age group.

Tracking Your Result Over Time

This is not a biomarker you track on a schedule the way you would track cholesterol or HbA1c. Stool PCR is ordered in response to a specific episode of diarrhea, and the result reflects that episode, not your long-term health trajectory. Repeat testing during the same illness is rarely useful: rapid retesting does not meaningfully increase sensitivity, and clinical practice generally discourages it unless something has clearly changed.

What does matter is acting on a positive result by tracking your symptom trajectory and any markers of severity (white blood cell count, kidney function, abdominal exam) over the first several days of treatment. If diarrhea resolves and you remain well, you are responding. If symptoms worsen or new abdominal pain develops, that pattern is more important than another PCR test. Test-of-cure is not recommended once treatment ends because PCR can stay positive long after live infection is gone.

Decision Pathway for an Unexpected Result

If your PCR comes back positive and you have active diarrhea, the standard next step in guideline-recommended algorithms is to confirm the picture with a stool toxin assay (immunoassay for toxin A and B), which is more specific for active disease. A PCR-positive, toxin-positive result combined with active symptoms supports a CDI diagnosis and is usually managed with targeted antibiotics under medical supervision. A PCR-positive, toxin-negative result in someone with mild symptoms often represents colonization or low-burden disease and may be observed rather than treated.

If your PCR is positive without diarrhea, treatment is generally not warranted; the result more likely reflects asymptomatic carriage. If your PCR is negative but symptoms persist, look for other causes: viral gastroenteritis, food poisoning, inflammatory bowel disease, microscopic colitis, medication side effects, or other gut pathogens. Specialty referral to a gastroenterologist or infectious disease physician is appropriate for severe presentations, recurrent infection, or cases complicated by inflammatory bowel disease or immunosuppression.